| Factor Information | |
|---|---|
| Data ID | 3929 |
| Factor | cTnI level on postoperative day |
| Description | The TGA group had a higher cTnI level on postoperative day 1 than the Stage 2 and 3 single ventricular palliation group. |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the correlation between the cTnI level and the postoperative stage in CHD patients. |
| p Value | 0.017 |
| Conclusion | The TGA group had a higher cTnI level on postoperative day 1 than the Stage 2 and 3 single ventricular palliation group |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 638 |
| CHD Type | isolated CHD |
| CHD Subtype | TGA/SV |
| Reference | |
|---|---|
| PMID | 31522246 |
| Year | 2019 |
| Title | Early assessment of cardiac troponin I predicts the postoperative cardiac status and clinical course after congenital heart disease surgery |
| Sample | ||
|---|---|---|
| Population | infants | |
| Source | patients | |
| Region | Saitama, Japan | |
| Method | The biochemical laboratory parameters were measured by a TBA-c16000 | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | cardiac surgery operation | |
| Group | TGA group in stage 1(Treatment) | single ventricular palliation group in stage 2 and 3(Control) |
| Number | 4 | 14 |
| Age | 19.9 ± 4.5 months | 19.9 ± 4.5 months |
| Gender (Male: Female) | 4:3 | 8:6 |
| Marker Level | 27.3 ± 5.8 ng/ml | 8.6 ± 3.4 ng/ml |
